Ovid Hosts Conference Call to Discuss Strategic Transaction Mar 3, 2021 8:30 AM EST Click here for webcast
Press Releases Year None2021202020192018201720162015 Jun 04, 2021 Ovid Therapeutics Appoints Jeff Rona as Chief Business and Financial Officer May 26, 2021 Ovid Therapeutics Appoints Dr. Joy A. Cavagnaro and Dr. Bruce A. Sullenger to its Scientific Advisory Board May 13, 2021 Ovid Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update May 12, 2021 Ovid Therapeutics to Participate in the 2021 RBC Capital Markets Global Healthcare Conference Apr 20, 2021 Ovid Therapeutics Announces Appointment of Professor Robert S. Langer, Sc.D., as Chair of its Scientific Advisory Board Pagination Current page 1 Page 2 Next page next › Last page last »
